JPRN-jRCT2080220502未知1 期
TK-FT Pharmacokinetic Study (Patients)
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •1)Patients who were diagnosed with cancer
- •2)Patients who were diagnosed as 0-2 by PS (ECOG Performance Status)
- •3)Patients who are 20-74 years old at the time of informed consent
- •4)Patients who are managed with opioid maintenance therapy for persistent cancer pain
- •5)Patients who are managed with rescue opioid for breakthrough cancer pain
排除标准
- •1)Patients with intolerance or history of previous allergies or sensitivity to fentanyl citrate, fentanyl or lactose
- •2)Patients with lung cancer
- •3)Patients with buccal, nasal or gastrointestinal cancer
- •4)Patients with history of buccal, nasal, pulmonary or gastro-intestinal disorders which in the opinion of the investigating physician will affect the absorption of study drug
- •5)Patients with organic encephalopathies such as intracranial hypertension, consciousness disturbed, coma or brain tumour
- •6)Patients with history of convulsive seizure
- •7)Patients with renal, hepatic, central nervous system, respiratory, cardiovascular or metabolic dysfunction , and with evidence of them
- •8)Patients with asthma
研究者
相似试验
已完成
1 期
A single injection dose study of DUR-928 in patients with impaired kidney function and healthy volunteersImpaired Kidney Function – stage 3 and 4Renal and Urogenital - Kidney diseaseACTRN12616000389404George Clinical Pty Ltd18
进行中（未招募）
不适用
The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaDiseases of the circulatory systemKCT0001258Hanlim Pharmaceutical40
已完成
不适用
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402KCT0003213avipharm38
已完成
不适用
Clinical study to investigate the pharmacokinetics, efficacy, safety and immunogenicity of human-cl rhFVIII in previously treated patients with severe haemophilia ASevere haemophilia AHaematological DisordersHereditary factor VIII deficiencyISRCTN87293301Octapharma AG (Switzerland)20
已完成
1 期
R3R01 single dose study in healthy adultsRenal and Urogenital - Other renal and urogenital disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersAlport syndromeFocal Segmental GlomerulosclerosisACTRN12621001019897River 3 Renal Corp24